Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: September 4, 2026 at 12:47 PM UTC
| NCT Number | NCT07517198 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of September 4, 2026: Clinical trial NCT07517198 is currently recruiting participants. This phase1 study for solid tumor is actively seeking new participants at 3 locations across the United States. The study is sponsored by Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07517198 is actively recruiting participants as of September 4, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07517198 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.